The Congestion "Pandemic" in Acute Heart Failure Patients.
Daniela MocanRadu Ioan LalaMaria PuschitaLuminița PilatDan Alexandru DarabantiuAdina Pop-MoldovanPublished in: Biomedicines (2024)
Congestion not only represents a cardinal sign of heart failure (HF) but is also now recognized as the primary cause of hospital admissions, rehospitalization, and mortality among patients with acute heart failure (AHF). Congestion can manifest through various HF phenotypes in acute settings: volume overload, volume redistribution, or both. Recognizing the congestion phenotype is paramount, as it implies different therapeutic strategies for decongestion. Among patients with AHF, achieving complete decongestion is challenging, as more than half still experience residual congestion at discharge. Residual congestion is one of the strongest predictors of future cardiovascular events and poor outcomes. Through this review, we try to provide a better understanding of the congestion phenomenon among patients with AHF by highlighting insights into the pathophysiological mechanisms behind congestion and new diagnostic and management tools to achieve and maintain efficient decongestion.
Keyphrases
- cardiovascular events
- acute heart failure
- heart failure
- liver failure
- coronary artery disease
- cardiovascular disease
- sars cov
- coronavirus disease
- intensive care unit
- risk factors
- left ventricular
- type diabetes
- metabolic syndrome
- drug induced
- hepatitis b virus
- ejection fraction
- insulin resistance
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome